.jpg?format=webp&quality=80&width=3840)
The study aimed to evaluate the impact of CFTR modulators on chronic rhinosinusitis (CRS) in adult patients with cystic fibrosis (CF). CRS was present in 83% of patients, but patient-reported scores did not correlate with objective disease severity. CFTR modulators were found to be promising as patients receiving them had significantly lower CT scores and less bacterial colonization. The study suggests that a multidisciplinary ENT-pneumology clinic would be beneficial for CF patients.
Like
Save
Share